CIK 0001856725 · <br>Emerging growth company
Rani Therapeutics Holdings, Inc.
Sign in to watch- Ticker
- RANI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 863114789
- Phone
- (408) 457-3700
- Business address
- 47709 FREMONT BLVD, FREMONT, CA, 94538
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 63 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-27 | Imran Talat Chief Executive Officer | Sale | −8,014 | $1.41 | $11K | 486,737 |
| 2024-12-16 | BUTEL JEAN LUC Director | Returned to the company · Stock Option (Right to Buy) | −101,276 | 0 | ||
| 2024-12-16 | BUTEL JEAN LUC Director | Grant or award · Stock Option (Right to Buy) | +101,276 | 101,276 | ||
| 2024-12-16 | BUTEL JEAN LUC Director | Returned to the company · Stock Option (Right to Buy) | −18,875 | 0 | ||
| 2024-12-16 | BUTEL JEAN LUC Director | Grant or award · Stock Option (Right to Buy) | +18,875 | 135,896 | ||
| 2024-12-16 | Ausiello Dennis A Director | Returned to the company · Stock Option (Right to Buy) | −101,276 | 0 | ||
| 2024-12-16 | Ausiello Dennis A Director | Grant or award · Stock Option (Right to Buy) | +101,276 | 101,276 | ||
| 2024-12-16 | Ausiello Dennis A Director | Returned to the company · Stock Option (Right to Buy) | −15,423 | 0 | ||
| 2024-12-16 | Ausiello Dennis A Director | Grant or award · Stock Option (Right to Buy) | +15,423 | 79,317 | ||
| 2024-12-16 | Rometty Lisa Ann Director | Returned to the company · Stock Option (Right to Buy) | −101,276 | 0 | ||
| 2024-12-16 | Rometty Lisa Ann Director | Grant or award · Stock Option (Right to Buy) | +101,276 | 101,276 | ||
| 2024-12-16 | Rometty Lisa Ann Director | Returned to the company · Stock Option (Right to Buy) | −17,708 | 0 | ||
| 2024-12-16 | Rometty Lisa Ann Director | Grant or award · Stock Option (Right to Buy) | +17,708 | 49,037 | ||
| 2024-12-16 | DEBUONO LAUREEN Director | Returned to the company · Stock Option (Right to Buy) | −101,276 | 0 | ||
| 2024-12-16 | DEBUONO LAUREEN Director | Grant or award · Stock Option (Right to Buy) | +101,276 | 101,276 | ||
| 2024-12-16 | DEBUONO LAUREEN Director | Returned to the company · Stock Option (Right to Buy) | −18,875 | 0 | ||
| 2024-12-16 | DEBUONO LAUREEN Director | Grant or award · Stock Option (Right to Buy) | +18,875 | 135,896 | ||
| 2024-12-16 | Farquharson Andrew Director | Returned to the company · Stock Option (Right to Buy) | −101,276 | 0 | ||
| 2024-12-16 | Farquharson Andrew Director | Grant or award · Stock Option (Right to Buy) | +101,276 | 101,276 | ||
| 2024-12-16 | IMRAN MIR A Director | Returned to the company · Stock Option (Right to Buy) | −101,276 | 0 |
Page 3 of 9 · 178 trades